Tasly Pharmaceutical Group Co., Ltd (SHA:600535)
13.97
-0.04 (-0.29%)
Sep 15, 2026, 3:00 PM CST
SHA:600535 Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, SHA:600535 stock has a consensus rating of "Buy" and an average price target of ¥17.29. The average 1-year stock price forecast is 23.77% higher than the current stock price, while the lowest is ¥14.80 (+5.94%) and the highest is ¥18.00 (+28.85%).
Price Target: ¥17.29 (+23.77%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for SHA:600535 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 3 |
| Buy | 2 | 2 | 2 | 2 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 4 | 5 |
Financial Forecast
Revenue This Year
8.63B
from 8.24B
Increased by 4.82%
Revenue Next Year
9.36B
from 8.63B
Increased by 8.37%
EPS This Year
0.84
EPS Next Year
0.95
from 0.84
Increased by 13.10%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.